The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
AI and the shift toward more integrated, efficient drug development
Explore how artificial intelligence is fundamentally changing biopharmaceutical development and how CDMO and CRO integration can act as an enabler for this future-forward technology.
Artificial intelligence is rapidly transforming drug development, yet for many organizations, its full potential remains out of reach. While adoption is widespread, most companies are still operating in isolated pilots—unable to scale AI across the full development lifecycle. As pressure intensifies to bring therapies to market faster and more efficiently, a new approach is emerging: one that combines advanced AI capabilities with integrated, end-to-end operating models.
In this article, originally featured in Pharma Ignite, you’ll discover how leading pharma and biotech companies are moving beyond fragmented systems to build connected ecosystems that enable smarter, faster decision-making. By aligning clinical development, supply chains, and manufacturing through shared data and digital infrastructure, organizations can unlock the full value of AI—reducing delays, improving visibility, and minimizing costly handoffs.
What you’ll learn in the article:
- Where AI is already delivering value in drug development
- How CDMO and CRO integration acts as a key enabler
- Strategies for operationalizing AI responsibly
- Why “agentic AI” is the next big development shaping the industry
- How expectations for speed and reliability are evolving
Download the full article to explore how intelligent integration is becoming the foundation of modern drug development—and what it means for your organization’s ability to compete in an increasingly complex, fast-moving landscape.
